Brief: Oriola Q1 EBITDA At EUR 5.3 Mln

Oriola Oyj

29/04/2026 06:39

April 29 (Reuters) - Oriola Oyj ORIOLA.HE:

Q1 EPS EUR -0.01

Q1 INVOICING INCREASED BY 8.1% TO EUR 1,081.2 (1,000.2) MILLION.

Q1 NET SALES DECREASED BY 2.2% TO EUR 49.8 (50.9) MILLION (EXCLUDING SWEDISH DOSE DISPENSING BUSINESS NET SALES GROWTH WAS 10.7%)

Q1 EBITDA WAS EUR 5.3 (6.0) MILLION INCLUDING ADJUSTING ITEMS OF EUR -2.4 (-1.6) MILLION.

IN 2026, PHARMACEUTICAL DISTRIBUTION MARKET IS EXPECTED TO CONTINUE TO GROW.

FOR 2026, ORIOLA EXPECTS ADJUSTED EBITDA TO INCREASE FROM PREVIOUS YEAR (2025: EUR 35.1 MILLION)

EXPECTATION OF IMPROVED ADJUSTED EBITDA IS BASED ON GROWING MARKETS AND STRATEGY EXECUTION.

Source text: ID:nWkr7nvN3m

Further company coverage: ORIOLA.HE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))